These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8544639)

  • 1. Hepatic purine and pyrimidine metabolism: implications for antiviral chemotherapy of viral hepatitis.
    Shaw T; Locarnini SA
    Liver; 1995 Aug; 15(4):169-84. PubMed ID: 8544639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presteady state kinetic investigation of the incorporation of anti-hepatitis B nucleotide analogues catalyzed by noncanonical human DNA polymerases.
    Brown JA; Pack LR; Fowler JD; Suo Z
    Chem Res Toxicol; 2012 Jan; 25(1):225-33. PubMed ID: 22132702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral chemotherapy for the treatment of hepatitis B virus infections.
    Torresi J; Locarnini S
    Gastroenterology; 2000 Feb; 118(2 Suppl 1):S83-103. PubMed ID: 10868900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of novel beta-L(-)-nucleoside analogues for treatment and prevention of chronic hepatitis B virus infection and hepatocellular carcinoma.
    Bridges EG; Cheng YC
    Prog Liver Dis; 1995; 13():231-45. PubMed ID: 9224504
    [No Abstract]   [Full Text] [Related]  

  • 5. The relative merits and drawbacks of new nucleoside analogues with clinical potential.
    Oberg B; Johansson NG
    J Antimicrob Chemother; 1984 Aug; 14 Suppl A():5-26. PubMed ID: 6436227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct notch signaling expression patterns between nucleoside and nucleotide analogues treatment for hepatitis B virus infection.
    Wang Z; Kawaguchi K; Honda M; Sakai Y; Yamashita T; Mizukoshi E; Kaneko S
    Biochem Biophys Res Commun; 2018 Jun; 501(3):682-687. PubMed ID: 29752943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium Purine Metabolism and Its Inhibition by Nucleoside and Nucleotide Analogues.
    Cheviet T; Lefebvre-Tournier I; Wein S; Peyrottes S
    J Med Chem; 2019 Sep; 62(18):8365-8391. PubMed ID: 30964283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Content of free nucleotides, nucleosides and purine and pyrimidine bases in certain tissues in normal and irradiated rabbits].
    RYSINA TN
    Biokhimiia; 1959; 24(3):556-62. PubMed ID: 13671022
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biological synthesis of purine and pyrimidine substances and of mononucleotides].
    EFIMOCHKINA EF; POZNANSKAIA AA
    Vopr Med Khim; 1957; 3(4):243-54. PubMed ID: 13468315
    [No Abstract]   [Full Text] [Related]  

  • 10. Progress towards improving antiviral therapy for hepatitis C with hepatitis C virus polymerase inhibitors. Part I: Nucleoside analogues.
    Brown NA
    Expert Opin Investig Drugs; 2009 Jun; 18(6):709-25. PubMed ID: 19426125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Nucleoside and Nucleotide Analogues in Tackling Human Immunodeficiency Virus and Hepatitis Virus Infections.
    Ramesh D; Vijayakumar BG; Kannan T
    ChemMedChem; 2021 May; 16(9):1403-1419. PubMed ID: 33427377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Delaney WE; Locarnini S; Shaw T
    Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of viral hepatitis.
    Hoofnagle JH
    Digestion; 1998 Aug; 59(5):563-78. PubMed ID: 9705540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity of antiretroviral nucleoside and nucleotide analogues: is mitochondrial toxicity the only mechanism?
    Moyle G
    Drug Saf; 2000 Dec; 23(6):467-81. PubMed ID: 11144657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New nucleoside analogues for chronic hepatitis B.
    Schalm SW; de Man RA; Heijtink RA; Niesters HG
    J Hepatol; 1995; 22(1 Suppl):52-6. PubMed ID: 7602078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver targeting of nucleoside analogues coupled to galactosyl terminating macromolecules: a new approach to the treatment of a chronic viral hepatitis.
    Fiume L; Verme G
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):275-80. PubMed ID: 9646223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future therapy for hepatitis B virus infection.
    Minami M
    Clin J Gastroenterol; 2015 Aug; 8(4):167-71. PubMed ID: 26265385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of action of interferon and nucleoside analogues.
    Thomas H; Foster G; Platis D
    J Hepatol; 2003; 39 Suppl 1():S93-8. PubMed ID: 14708685
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues.
    Dusheiko G
    Liver Int; 2013 Feb; 33 Suppl 1():137-50. PubMed ID: 23286858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human and viral nucleoside/nucleotide kinases involved in antiviral drug activation: structural and catalytic properties.
    Deville-Bonne D; El Amri C; Meyer P; Chen Y; Agrofoglio LA; Janin J
    Antiviral Res; 2010 Apr; 86(1):101-20. PubMed ID: 20417378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.